The pharmacology of human anxiety
DJ Nutt - Pharmacology & therapeutics, 1990 - Elsevier
The human pharmacology of anxiety disorders, including panic disorder, is detailed. The
major theories center around the role of benzodiazepine receptor, noradrenergic and …
major theories center around the role of benzodiazepine receptor, noradrenergic and …
Neurobiologic basis of anxiety and its treatment
C Salzman, EK Miyawaki, P le Bars… - Harvard Review of …, 1993 - Taylor & Francis
Current evidence suggests that anxiety has a neurobiologic basis. It is thought to be caused
by dysfunction of one or more neurotransmitters and their receptors. Most data, which are …
by dysfunction of one or more neurotransmitters and their receptors. Most data, which are …
The neurochemistry of anxiety: an update
DJ Nuit, P Que, C Iawson - Progress in Neuro-Psychopharmacology and …, 1990 - Elsevier
1. Recent neurochemical investigations have enhanced our understanding of the anxiety
disorders. Enphasis has been placed on dysfunction in central benzodiazepine …
disorders. Enphasis has been placed on dysfunction in central benzodiazepine …
Neurochemical basis for anxiety and anxiety disorders: evidence from drugs which decrease human fear or anxiety
DE Redmond - Anxiety and the anxiety disorders, 2019 - taylorfrancis.com
This chapter reviews the biochemical effects of anxiolytic drugs to determine whether
significant common mechanisms can be found. Since anxiety and fear can be observed …
significant common mechanisms can be found. Since anxiety and fear can be observed …
States of anxiety and their induction by drugs.
M Lader, M Bruce - British Journal of Clinical Pharmacology, 1986 - Wiley Online Library
Syndromes of anxiety include generalized anxiety states, various forms of phobic disorder
and panic attacks. It is unclear whether panic attacks are a separate syndrome from anxiety …
and panic attacks. It is unclear whether panic attacks are a separate syndrome from anxiety …
New concepts in the neurobiology of anxiety.
P Skolnick, SM Paul - The Journal of clinical psychiatry, 1983 - europepmc.org
Advances in understanding the neurobiologic bases of anxiety are reviewed. The discovery
of a class of compounds generically known as" benzodiazepine antagonists" has been …
of a class of compounds generically known as" benzodiazepine antagonists" has been …
Pharmacologic models of anxiety.
LB Guttmacher, DL Murphy, TR Insel - Comprehensive psychiatry, 1983 - psycnet.apa.org
Discusses some of the potential benefits of drug-induced models of anxiety, reviews the
literature in this area, and characterizes an ideal model of anxiety. Rationales for …
literature in this area, and characterizes an ideal model of anxiety. Rationales for …
The psychobiology of anxiolytic drugs: Part 1: Basic neurobiology
JJ Sandford, SV Argyropoulos, DJ Nutt - Pharmacology & therapeutics, 2000 - Elsevier
The authors provide an overview of the current state of knowledge with regards to the
neurobiological mechanisms involved in normal and pathological anxiety. A brief review of …
neurobiological mechanisms involved in normal and pathological anxiety. A brief review of …
Overview of anxiety disorders: prevalence, biology, course, and treatment.
AF Schatzberg - The Journal of clinical psychiatry, 1991 - europepmc.org
Anxiety disorders are extremely common in modern society. The Epidemiologic Catchment
Area (ECA) Study reported a 1-month prevalence for anxiety disorders of 7.3%, and a …
Area (ECA) Study reported a 1-month prevalence for anxiety disorders of 7.3%, and a …
[图书][B] Anxiety disorders: pathophysiology and pharmacological treatment
G Emilien, C Durlach, U Lepola, T Dinan - 2002 - books.google.com
In this book, the discussion of the normal and pathological aspects of anxiety is critically
examined. A chapter on the molecular basis of anxiety is included, outlining the potential of …
examined. A chapter on the molecular basis of anxiety is included, outlining the potential of …